PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP InhibitorsKonstantin J. Dedes, Jorge S. Reis‐Filho, Daniel Wetterskog et al.|Science Translational Medicine|2010Cited by 257
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancersDaniel Wetterskog, Britta Weigelt, M. Ángeles López‐García et al.|The Journal of Pathology|2011Cited by 168
Functional Viability Profiles of Breast CancerRachel Brough, Alan Ashworth, Jessica Frankum et al.|Cancer Discovery|2011Cited by 143
Functional characterization of the 19q12 amplicon in grade III breast cancersRachael Natrajan, Jorge S. Reis‐Filho, Alan Mackay et al.|Breast Cancer Research|2012Cited by 95
Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancersDaniel Wetterskog, Alan Ashworth, K-K. Shiu et al.|Oncogene|2013Cited by 52